KR102596798B1 - 동결 건조된 2-[(3-아미노프로필)아미노]에탄티올 제제의 제조 방법 - Google Patents

동결 건조된 2-[(3-아미노프로필)아미노]에탄티올 제제의 제조 방법 Download PDF

Info

Publication number
KR102596798B1
KR102596798B1 KR1020197016544A KR20197016544A KR102596798B1 KR 102596798 B1 KR102596798 B1 KR 102596798B1 KR 1020197016544 A KR1020197016544 A KR 1020197016544A KR 20197016544 A KR20197016544 A KR 20197016544A KR 102596798 B1 KR102596798 B1 KR 102596798B1
Authority
KR
South Korea
Prior art keywords
amifostine
solution
gel
amino
aminopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020197016544A
Other languages
English (en)
Korean (ko)
Other versions
KR20190085526A (ko
Inventor
슈핑 왕-장
페린 피베트
카린 곤잘레즈
에릭 도이치
셀린 클레멘슨
Original Assignee
클레베젤 파르마
인스티튜트 구스타브 루시
유니베르시떼 파리-싸끌레
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 클레베젤 파르마, 인스티튜트 구스타브 루시, 유니베르시떼 파리-싸끌레 filed Critical 클레베젤 파르마
Publication of KR20190085526A publication Critical patent/KR20190085526A/ko
Application granted granted Critical
Publication of KR102596798B1 publication Critical patent/KR102596798B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1020197016544A 2016-11-30 2017-11-29 동결 건조된 2-[(3-아미노프로필)아미노]에탄티올 제제의 제조 방법 Active KR102596798B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16306582.4 2016-11-30
EP16306582.4A EP3330251A1 (en) 2016-11-30 2016-11-30 Process for the preparation of freeze-dried 2-[(3-aminopropyl)amino]ethanethiol
PCT/EP2017/080881 WO2018100008A1 (en) 2016-11-30 2017-11-29 Process for the preparation of freeze-dried 2-[(3-aminopropyl)amino]ethanethiol formulation

Publications (2)

Publication Number Publication Date
KR20190085526A KR20190085526A (ko) 2019-07-18
KR102596798B1 true KR102596798B1 (ko) 2023-10-31

Family

ID=57542923

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197016544A Active KR102596798B1 (ko) 2016-11-30 2017-11-29 동결 건조된 2-[(3-아미노프로필)아미노]에탄티올 제제의 제조 방법

Country Status (11)

Country Link
US (1) US11021442B2 (https=)
EP (2) EP3330251A1 (https=)
JP (1) JP7138104B2 (https=)
KR (1) KR102596798B1 (https=)
CN (1) CN110300742B (https=)
AU (1) AU2017369603B2 (https=)
CA (1) CA3039425A1 (https=)
IL (1) IL266811B (https=)
MX (1) MX386559B (https=)
WO (1) WO2018100008A1 (https=)
ZA (1) ZA201902119B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824880A1 (en) * 2019-11-25 2021-05-26 Clevexel Pharma Freeze-dried powder containing 2-[(3-aminopropyl)amino]ethanethiol and its use for preparing a thermogel
EP4303224A4 (en) * 2021-03-03 2025-02-19 Tohoku University PROTEIN FOLDING AGENTS
CN116283682B (zh) * 2023-02-21 2024-08-02 梯尔希（南京）药物研发有限公司 一种同位素标记的氨磷汀代谢物的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529519A (ja) 1998-11-16 2002-09-10 メドイミューン オンコロジー，インコーポレーテッド 安定な非晶質アミフォスチン組成物およびその製造法および使用法
JP2015526505A (ja) * 2012-08-31 2015-09-10 アシスタンス プブリク−オピトウ ドゥ パリ ケタミンを含有するゲル化製剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU670567A1 (ru) * 1978-02-06 1979-06-30 Предприятие П/Я В-2343 Способ получени дихлоргидрата бета-меркаптоэтил-1,3-пропилендиамина
US6239119B1 (en) 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
MXPA03004546A (es) * 2000-11-22 2003-09-10 Rxkinetix Inc Tratamiento de mucositis.
WO2013163423A1 (en) * 2012-04-25 2013-10-31 Musc Foundation For Research Development Compositions and methods for wound healing and tissue repair

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002529519A (ja) 1998-11-16 2002-09-10 メドイミューン オンコロジー，インコーポレーテッド 安定な非晶質アミフォスチン組成物およびその製造法および使用法
JP2015526505A (ja) * 2012-08-31 2015-09-10 アシスタンス プブリク−オピトウ ドゥ パリ ケタミンを含有するゲル化製剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Environ.Mol.Mutagen, Vol.50, pp.460-472, 2009*

Also Published As

Publication number Publication date
IL266811A (en) 2019-07-31
AU2017369603B2 (en) 2021-04-29
MX386559B (es) 2025-03-19
JP7138104B2 (ja) 2022-09-15
US20200239414A1 (en) 2020-07-30
EP3330251A1 (en) 2018-06-06
KR20190085526A (ko) 2019-07-18
BR112019011006A2 (pt) 2019-10-08
BR112019011006A8 (pt) 2023-04-11
IL266811B (en) 2021-10-31
EP3548464A1 (en) 2019-10-09
CN110300742A (zh) 2019-10-01
WO2018100008A1 (en) 2018-06-07
CN110300742B (zh) 2022-02-18
CA3039425A1 (en) 2018-06-07
JP2019535801A (ja) 2019-12-12
AU2017369603A1 (en) 2019-05-02
ZA201902119B (en) 2023-01-25
MX2019006310A (es) 2019-08-12
US11021442B2 (en) 2021-06-01

Similar Documents

Publication Publication Date Title
KR102596798B1 (ko) 동결 건조된 2-[(3-아미노프로필)아미노]에탄티올 제제의 제조 방법
US20260041774A1 (en) Compositions for retarding the decomposition of melatonin in solution
EP3236938B1 (en) Oral topical aqueous pharmaceutical compositions of flurbiprofen and dexpanthenol
MX2025001642A (es) Tratamiento del cancer de piel
MX2023001572A (es) Formas farmaceuticas sólidas de palbociclib.
TWI905111B (zh) 含有對硼苯基丙胺酸之注射液劑
BR112019011006B1 (pt) Composição de termogel, processo para a preparação de uma composição de termogel e usos da composição de termogel
KR20220062368A (ko) p-보로노페닐알라닌을 함유하는 주사액제의 석출 방지 방법
KR20210062399A (ko) 방사선 조사에 의한 조직 또는 세포 손상의 예방 또는 치료용 약학적 조성물
ES2895402T3 (es) Derivados de aminoácidos y sus usos
KR101625926B1 (ko) 포스포디에스터라제 타입-5 억제제의 경피 전달을 향상시키는 방법 및 포스포디에스터라제 타입-5 억제제의 경피 전달을 향상시키는 개선된 약학적 조성물
AU2020393375B2 (en) Freeze-dried powder containing 2-[(3-aminopropyl)amino]ethanethiol and its use for preparing a thermogel
JP6795330B2 (ja) トリアムシノロンアセトニド含有口腔粘膜用組成物
US11090290B2 (en) Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy
EP3834815A1 (en) Topical aqueous pharmaceutical compositions of flurbiprofen and chlorhexidine
KR20070083272A (ko) 피부 투과율이 개선된 안드로겐 함유 경피흡수용 겔 조성물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20190610

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20201014

Comment text: Request for Examination of Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20220527

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20221024

Patent event code: PE09021S01D

E90F Notification of reason for final refusal
PE0902 Notice of grounds for rejection

Comment text: Final Notice of Reason for Refusal

Patent event date: 20230418

Patent event code: PE09021S02D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230829

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20231027

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20231027

End annual number: 3

Start annual number: 1

PG1601 Publication of registration